BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20360961)

  • 41. Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim.
    Bélec L; Matta M; Payan C; Tévi-Bénissan C; Meillet D; Pillot J
    J Med Virol; 1995 Jan; 45(1):113-6. PubMed ID: 7714486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.
    Muster T; Ferko B; Klima A; Purtscher M; Trkola A; Schulz P; Grassauer A; Engelhardt OG; García-Sástre A; Palese P
    J Virol; 1995 Nov; 69(11):6678-86. PubMed ID: 7474077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.
    Dorrell L; Hessell AJ; Wang M; Whittle H; Sabally S; Rowland-Jones S; Burton DR; Parren PW
    AIDS; 2000 Jun; 14(9):1117-22. PubMed ID: 10894275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.
    Lê MP; Belarbi L; Chaix ML; Dulioust E; Mahjoub N; Salmon D; Viard JP; Duvivier C; Peytavin G; Launay O; Ghosn J
    J Antimicrob Chemother; 2017 Nov; 72(11):3167-3171. PubMed ID: 28961979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission.
    Anderson DJ; Politch JA; Tucker LD; Fichorova R; Haimovici F; Tuomala RE; Mayer KH
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S43-9. PubMed ID: 9581883
    [No Abstract]   [Full Text] [Related]  

  • 47. Chlamydia trachomatis and male infertility: chlamydia-IgA antibodies in seminal plasma are C. trachomatis specific and associated with an inflammatory response.
    Ochsendorf FR; Ozdemir K; Rabenau H; Fenner T; Oremek R; Milbradt R; Doerr HW
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):143-52. PubMed ID: 10343944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.
    Johansson EL; Wassén L; Holmgren J; Jertborn M; Rudin A
    Infect Immun; 2001 Dec; 69(12):7481-6. PubMed ID: 11705923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
    Astronomo RD; Lemos MP; Narpala SR; Czartoski J; Fleming LB; Seaton KE; Prabhakaran M; Huang Y; Lu Y; Westerberg K; Zhang L; Gross MK; Hural J; Tieu HV; Baden LR; Hammer S; Frank I; Ochsenbauer C; Grunenberg N; Ledgerwood JE; Mayer K; Tomaras G; McDermott AB; McElrath MJ
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34166231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae.
    Marlin R; Nugeyre MT; Tchitchek N; Parenti M; Lefebvre C; Hocini H; Benjelloun F; Cannou C; Nozza S; Dereuddre-Bosquet N; Levy Y; Barré-Sinoussi F; Scarlatti G; Le Grand R; Menu E
    Front Immunol; 2019; 10():430. PubMed ID: 30915079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucosal antibody responses to HIV.
    Moldoveanu Z; Mestecky J
    Methods Mol Biol; 2009; 485():333-45. PubMed ID: 19020835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions, but elicit poor LCMV-specific IgA.
    Rajini B; Zeng J; Suvas PK; Dech HM; Onami TM
    Viral Immunol; 2010 Aug; 23(4):377-84. PubMed ID: 20712482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis.
    Derksen VFAM; Allaart CF; Van der Helm-Van Mil AHM; Huizinga TWJ; Toes REM; van der Woude D
    Rheumatology (Oxford); 2022 Dec; 62(1):407-416. PubMed ID: 35416963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
    Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
    Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of semen in HIV-1 transmission: inhibitor or facilitator?
    Doncel GF; Joseph T; Thurman AR
    Am J Reprod Immunol; 2011 Mar; 65(3):292-301. PubMed ID: 21087339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments.
    Albritton HL; Kozlowski PA; Lillis RA; McGowin CL; Siren JD; Taylor SN; Ibana JA; Buckner LR; Shen L; Quayle AJ
    PLoS One; 2017; 12(8):e0183101. PubMed ID: 28797112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients.
    Kaushik K; Khurana S; Wanchu A; Malla N
    BMC Infect Dis; 2009 Nov; 9():179. PubMed ID: 19922628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
    Engström PE; Gustafson R; Granberg M; Engström GN
    Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.